Elizabeth Garner

Dr. Elizabeth Garner has well over a decade of experience in the pharmaceutical industry, and brings wide expertise in drug development, including assessment of early- and late-stage product candidates, clinical trial design and conduct, regulatory and FDA Advisory Committee strategy and execution.

Dr. Garner’s current position is the Chief Medical Officer at Obseva SA. From 2014 to 2019, Dr. Garner was Chief Medical Officer of Agile Therapeutics. Dr. Garner was VP of Medical Affairs at Myriad Genetics. Earlier in her career she was Senior Director of Clinical Research at Abbott Laboratories. Dr. Garner was Associate Director, then Director of Clinical Research at Merck Research Laboratories.

Dr. Garner received joint M.D. and M.P.H degrees from Harvard Medical School and Harvard School of Public Health. She was trained in obstetrics and gynecology at Brigham and Women’s/Massachusetts General Hospitals and completed a fellowship in gynecologic oncology at Brigham and Women’s Hospital and the Dana Farber Cancer Institute.

In addition to the Sermonix Board, Dr. Garner’s current corporate board positions include Kezar Life Sciences and the global CRO Pharm-Olam International. She is also on the board of the Drug Information Association and serves on the Executive Committee as Treasurer of the American Medical Women’s Association (AMWA), and is a board member of CorStone.